Now welcoming new patients 4.9 on Google Pay Your Bill · Pay Scheduling Fee Call (225) 647-2294
Ascension Center for Women's Health
Book
Menu

Home / Education / Pelvic & Sexual Health

Pelvic & Sexual Health

Vaginal Dryness: Why It Happens and What Actually Treats It

Written byJason D. Adams, MD, FACOG
Reading time4 min read
A couple in their fifties walking hand in hand along a bayou boardwalk at golden hour

In brief

It affects about half of postmenopausal women, very few mention it, and unlike hot flashes it does not resolve on its own. It is also one of the more reliably treatable things I see. Here are the options, plainly.

On this page

Vaginal dryness is one of the most common consequences of falling estrogen, and one of the least often raised in the exam room. It is treatable — usually straightforwardly — and unlike hot flashes, which typically ease with time, it does not resolve on its own. Left alone it is generally progressive.1,2 That is the single most important thing to know.

Why it happens

The tissue of the vulva and vagina is estrogen-dependent. As estrogen falls — through perimenopause, menopause, after certain breast cancer treatments, after surgical removal of the ovaries, and sometimes while breastfeeding — that tissue becomes thinner, less elastic, and produces less natural lubrication. Blood flow decreases and the local pH shifts.

The clinical name for the fuller picture is genitourinary syndrome of menopause, because it is not only about dryness. The same tissue change explains urinary urgency, recurrent urinary tract infections, and discomfort that has nothing to do with intimacy.

What patients actually describe

  • Dryness or a raw, irritated feeling that is present day to day, not only during intimacy.
  • Pain or burning with intercourse — often the symptom that finally prompts the appointment.
  • Light bleeding or spotting afterwards.
  • Itching or a sensation of tightness.
  • Urinary urgency, frequency, or repeated urinary tract infections without an obvious cause.
  • Discomfort from clothing, exercise, or sitting for long periods.

Roughly half of postmenopausal women experience some form of this — published estimates run from about a quarter to more than eighty percent, depending on how it is defined and how directly women are asked.1,3 A much smaller share ever mention it: only about half of women with symptoms report ever discussing them with a clinician, and most of those say the clinician did not raise it first.3 In twenty-one years of practice I have had a great many women tell me they assumed it was simply part of aging and there was nothing to be done. That is not correct, and it is the reason I raise it rather than waiting to be asked.

Why it goes unmentioned — and why that costs something

Two reasons, usually. It feels embarrassing to raise, and many women assume it is untreatable. Meanwhile, unlike hot flashes and night sweats — which typically ease over several years — genitourinary symptoms are progressive. Waiting does not help.

If you take one thing from this article: you do not have to raise it. Write it on your intake form, or say "I read the article about dryness." That is enough. We will take it from there.

What the treatment options actually are

There are more than most people expect, and they range from entirely non-hormonal to prescription.

  • Vaginal moisturizers. Used regularly, not only before intimacy. Non-hormonal, available over the counter, and genuinely effective for milder symptoms.
  • Lubricants. For use during intimacy. Different from moisturizers and they solve a different part of the problem — most women benefit from both.
  • Low-dose vaginal estrogen. Cream, tablet or ring. Acts locally on the tissue with minimal systemic absorption. For most women this is the most effective option, and it is a different proposition from systemic hormone therapy.
  • Vaginal DHEA (prasterone). A prescription non-estrogen alternative.
  • Ospemifene. An oral non-estrogen prescription option for painful intercourse.
  • Systemic hormone therapy. Appropriate when dryness sits alongside hot flashes, sleep disruption and other symptoms that call for whole-body treatment.
  • Pelvic floor treatment. Where pain involves muscle tension as well as tissue change, addressing the tissue alone will not be enough.

Which of these is right depends on your symptoms, your history and your preference. It is a genuine conversation, not a protocol.

The question I am asked most: is vaginal estrogen safe?

It is the first question nearly every woman asks, usually having read something alarming about hormones.

Low-dose vaginal estrogen is dosed locally and produces very little systemic absorption — which is why it is regarded differently from systemic hormone therapy, and why it is often appropriate for women who cannot or prefer not to take systemic hormones. Major professional bodies including ACOG and The Menopause Society support its use for genitourinary symptoms.

There are situations that require individual discussion, particularly a personal history of breast cancer, where the decision should involve your oncologist. That is a conversation to have, not a closed door. I would rather have it with you than have you decide alone based on a package insert.

What a visit involves

A history, an examination, and a conversation about what you want to change. Where symptoms are more urinary than vaginal, we will look at that too, since the same tissue change frequently drives both. If a pelvic floor component is contributing, we have options for that as well.

Most women notice improvement within a few weeks, with the fuller benefit usually taking eight to twelve weeks of consistent use.2 It is one of the more reliably treatable things I see, which is what makes it a shame that it so often goes unsaid.

References

  1. The North American Menopause Society. The 2020 genitourinary syndrome of menopause position statement. Menopause. 2020;27(9):976–992. Reports a published prevalence range of 27–84% and describes GSM as generally progressive without treatment.
  2. Faubion SS, Sood R, Kapoor E. Genitourinary syndrome of menopause: management strategies for the clinician. Mayo Clin Proc. 2017;92(12):1842–1849.
  3. American Urological Association, SUFU and AUGS. Genitourinary Syndrome of Menopause: AUA/SUFU/AUGS Guideline. 2025. Source for the finding that only about half of women with symptoms discuss them with a clinician.

Keep reading

This article is educational and is not medical advice. It does not create a patient relationship. Treatment options may be available when clinically appropriate, and results vary from person to person. If you are experiencing a medical emergency, call 911.

Ready when you are

Ready to take the next step?

Start with a free consultation — a real conversation, no obligation.

Visit us1943 S. Burnside Avenue
Gonzales, LA 70737
Get directions →
Office hours
Mon, Tue, Thu
8:00 – 5:00
Wednesday
9:30 – 5:00
Friday
8:00 – 12:00
Sat & Sun
Closed
Book a VisitCall